Adiponectin in non-alcoholic steatohepatitis: An ideal culprit, but what are the proofs of its guilt?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 10, 2009, Pages 1584-1586

  Lanthier, Nicolas ^a   Leclercq, Isabelle A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; COLLAGEN TYPE 1; TUMOR NECROSIS FACTOR;

CARCINOGENESIS; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; INFLAMMATION; LIPID DIET; LIPID METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WEIGHT GAIN; WILD TYPE;

EID: 70349687249     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06087.x     Document Type: Editorial

References (19)

1. Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J. Gastroenterol. 2008 43 : 811 822.
2. Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology 2008 15 : 91 101.
3. Xu AM, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 2003 112 : 91 100.
4. Da Silva MA, Lebrun V, Abarca-Quinones J et al. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation. J. Hepatol. 2009 50 : 489 500.
5. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999 257 : 79 83.
6. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000 20 : 1595 1599.
7. Jiang LL, Li L, Hong XF, Li YM, Zhang BL. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. Eur. J. Gastroenterol. Hepatol. 2009 21 : 662 666.
8. Aygun C, Senturk O, Hulagu S et al. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 2006 18 : 175 180.
9. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004 40 : 46 54.
10. Bugianesi E, Pagotto U, Manini R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J. Clin. Endocrinol. Metab. 2005 90 : 3498 3504.
11. Kaser S, Moschen A, Cayon A et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005 54 : 117 121. (Pubitemid 40007229)
12. Ma H, Gomez V, Lu L, Yang XJ, Wu XY, Xiao SY. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2009 24 : 233 237.
13. Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J. Hepatol. 2008 49 : 407 416.
14. Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002 8 : 731 737.
15. Kubota N, Terauchi Y, Yamauchi T et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 2002 277 : 25863 25866.
16. Ma K, Cabrero A, Saha PK et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 2002 277 : 34658 34661.
17. Thamer C, Haap M, Bachmann O et al. Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia 2004 47 : 1303 1305.
18. Kamada Y, Matsumoto H, Tamura S et al. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J. Hepatol. 2007 47 : 556 564.
19. Asano T, Watanabe K, Kubota N et al. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. J. Gastroentreol. Hepatol. 2009 24 : 1669 1676.